北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 977-981. doi: 10.3969/j.issn.1671-167X.2016.06.010

• 论著 • 上一篇    下一篇

离子型谷氨酸受体拮抗剂MK-801和NBQX对胶原诱导型关节炎大鼠的镇痛作用

朱惠*,朱蓉*,邓肇达,封昱辰,沈海丽△   

  1. (兰州大学第二医院风湿免疫科,兰州730000)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 沈海丽 E-mail:shl523194@sohu.com
  • 基金资助:

    甘肃省科技支撑计划基金(144FKCA060)及甘肃省卫生行业科研计划管理项目(GWGL2014-50)资助

Analgesic effects of ionotropic glutamate receptor antagonists MK-801 and NBQX on collagen-induced arthritis rats

ZHU Hui*, ZHU Rong*, DENG Zhao-da, FENG Yu-chen, SHEN Hai-li△   

  1. (Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730000, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: SHEN Hai-li E-mail:shl523194@sohu.com
  • Supported by:

    Supported by Gansu Pro-vince Science and Technology Support Plan Fund (144FKCA060) and Health Industry in Gansu Province Scientific Research Plan Management Program (GWGL2014-50)

摘要:

目的:在大鼠胶原诱导关节炎( collagen-induced arthritis,CIA )模型中,使用不同离子型谷氨酸受体拮抗剂,即N-甲基-D-天冬氨酸(N-methyl-D-asparticacid,NMDA)受体拮抗剂MK-801及非NMDA受体拮抗剂NBQX,通过阻断谷氨酸与相应受体结合而产生镇痛作用,进而研究两种拮抗剂在镇痛作用方面对大鼠行为的影响,以及对分子生物学指标产生的影响,即应用上述拮抗剂后大鼠血清及组织液中环氧化酶-2(cyclooxygenase-2,COX-2)和Janus激酶-3(Janus-activated kinase,Jak3)等表达的变化。方法: 建立大鼠CIA模型,通过体内研究,向大鼠关节腔内注射不同离子型谷氨酸受体拮抗剂MK-801和NBQX,观察CIA大鼠行为和分子生物学指标的改变。行为评估内容包括大鼠的触痛及关节肿胀情况,触痛情况使用机械性缩足阈值(paw-withdrawal threshold,PWT)来评价,同时使用排水法测足容积来评估肿胀情况。分子生物学指标相关研究即由大鼠心脏采血,并取组织匀浆液,检测血清及组织液中在拮抗剂使用后COX-2和Jak3等表达的变化。结果: MK-801和 NBQX在单独或联合使用时均能表现出镇痛作用(P<0.01), 且镇痛作用持续时间均大于24 h,两种拮抗剂均在注射后4 h达到镇痛作用的峰值,且NBQX比MK-801镇痛作用更强(P<0.05);MK-801和 NBQX在单独及联合使用时,均不能改变CIA大鼠的足跖肿胀(P>0.05);MK-801可降低CIA大鼠COX-2的表达(P<0.01),NBQX则未见此作用(P>0.05);MK-801和NBQX对CIA大鼠的Jak3表达增高均未见产生影响(P>0.05)。结论: MK-801及NBQX均可产生镇痛作用,且NBQX比MK-801表现更强,但两者对肿胀均未见效果;NMDA受体与COX-2炎症通路有一定的交叉作用,而对于Jak3尚不能发现其与离子型谷氨酸信号通路存在交叉作用。

关键词: 关节炎, 类风湿, 谷氨酸, 受体, 炎症, 疼痛

Abstract:

Objective: The ionotropic glutamate receptorantagonists include two types: MK-801, anta-gonist of N-methyl-D-asparticacid (NMDA) receptor, and NBQX, antagonist of non-NMDA receptor.The above-mentioned ionotropic antagonists can block the glutamate and its corresponding receptor binding to produce analgesic effect. The objective of this research was to study two antagonists in analgesic effect on rat behavior,as well as to investigate the down-regulation and up-regulation of cyclooxygenase-2 (COX-2) and Janus-activated kinase (Jak3) in collagen-induced arthritis (CIA) rat serum and tissue fluid after the application of these antagonists, that is, the effect on molecular biology. Methods: This study used the ionotropic glutamate receptors as the target and established CIA rat model. Vivo studies were used to observe changes in behavior and molecular biology of the CIA rat.Behavioral assessment includedmechanical allodynia and joint swelling in the CIA rat,where themechanical allodynia was measured using the paw-withdrawal threshold (PWT) with VonFrey filaments according to the “Up-Down” method,and the drainage volume was used to assess joint swelling. Then the blood samples taken from the heart of the rat and the tissue homogenate were collected to detect the down-regulation and up-regulation of COX-2 and Jak3 in the serum and tissue fluid after the antagonists wereused. Results: Using MK-801, NBQX alone or using the combination of these two antagonists,these three methods all could alleviate pain(P<0.01).The analgesic effect lasted more than 24 h.Both antagonists reached the peak of analgesia at the end of 4 hours post-injection.NBQX had stronger analgesic effect than MK-801 (P<0.05).Whether alone or combined use of these two antagonists,could not change the CIA rats’ swelling of the joint (P>0.05). MK -801 could decrease the expression of COX-2 (P<0.01).At the same time, NBQX did not have this effect (P>0.05). Using MK-801, NBQX alone or combination of these two antagonists could not affect the increased expression of Jak3 caused by the CIA (P>0.05). Conclusion: MK-801 and NBQX could both alleviate pain, NBQX was much better than MK-801. Neither MK-801 nor NBQX had the effect on the swelling of the joint. NMDA receptor and COX-2 inflammatory pathways had certain interactions. For Jak3, it could not be found to have cross-function with ionotropic glutamate signaling pathways by this experiment.

Key words: Arthritis, rheumatoid, Glutamic acid, Receptor, Inflammation, Pain

中图分类号: 

  • R593
[1] 魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报(医学版), 2026, 58(2): 307-312.
[2] 温倩颖, 张丽卿, 秦安霖, 李小峰. 无症状高尿酸血症患者小肠细菌过度生长及炎症细胞因子表达水平[J]. 北京大学学报(医学版), 2026, 58(2): 313-318.
[3] 汤晓菲, 丁秋玲, 张阳, 王育梅, 田美伊, 孙卓, 王荣荣, 陈妍, 刘坚. 阿伐曲泊帕治疗难治性系统性红斑狼疮相关血小板减少1例[J]. 北京大学学报(医学版), 2026, 58(2): 405-409.
[4] 吴滔, 林建子, 朱亚锋, 马剑达, 贾霈雯, 杨莉娟, 潘婕, 邹耀威, 杨迎, 卢烨, 戴冽. 血清蛋白质谱筛选及验证类风湿关节炎患者肌肉量减少的生物标志物[J]. 北京大学学报(医学版), 2025, 57(6): 1024-1031.
[5] 高雅静, 李正芳, 马梦思, 武丽君. SII和SIRI对白塞病葡萄膜炎的风险预测及疾病活动度和预后的评估[J]. 北京大学学报(医学版), 2025, 57(6): 1067-1073.
[6] 王翠萍, 陈哲, 程永静. 超微血流成像评估与膝骨关节炎临床症状的关联研究[J]. 北京大学学报(医学版), 2025, 57(6): 1096-1100.
[7] 董琪, 何菁, 贾园, 姚海红, 张霞. 模拟复发性多软骨炎的VEXAS综合征1例[J]. 北京大学学报(医学版), 2025, 57(6): 1180-1183.
[8] 吕雪冰, 俞烜华, 张伟桢, 刘昌泉, 林互涵, 曾珊婷, 黄惠娟, 吴月萍. 类风湿关节炎合并坏死性筋膜炎1例[J]. 北京大学学报(医学版), 2025, 57(6): 1198-1202.
[9] 丁艳, 王丽芳, 李超然, 卢哲敏, 石连杰. 利妥昔单抗成功治疗类风湿关节炎合并IgG4相关性疾病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1203-1207.
[10] 朱丽秀, 陈仁利, 周素娟, 林烨, 汤一榕, 叶桢. 水通道蛋白5对干燥综合征大鼠TLR4/MyD88/NF-κB信号的影响[J]. 北京大学学报(医学版), 2025, 57(5): 875-883.
[11] 杨菊, 徐婧, 戴菊华, 石连杰. Lumican蛋白在类风湿关节炎患者血清中的表达及其与疾病和免疫活动的相关性[J]. 北京大学学报(医学版), 2025, 57(5): 911-918.
[12] 冯亮华, 洪丽荣, 陈雨佳, 蔡学明. 泛素特异性蛋白酶35对类风湿关节炎成纤维样滑膜细胞铁死亡的作用及机制[J]. 北京大学学报(医学版), 2025, 57(5): 919-925.
[13] 包振英, 王雅杰. 炎症指标和细胞因子联合检测在慢性牙周炎中的应用[J]. 北京大学学报(医学版), 2025, 57(4): 772-778.
[14] 霍梦月, 梅花, 张钰恒, 张艳波, 刘春丽. miR-34a在高氧诱导新生大鼠支气管肺发育不良模型中的表达及调控机制[J]. 北京大学学报(医学版), 2025, 57(2): 237-244.
[15] 刘慧丽, 闻蓓, 白雪, 陈明安, 李民. 体重校正腰围指数与疼痛的相关性:一项横断面研究[J]. 北京大学学报(医学版), 2025, 57(1): 178-184.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!